[Endocrine disruptors and fertility: NR0B2, a new therapeutic target?].
Decourteix
Mélanie
M
Volle
David H
DH
D000818:Animals; D000831:Animals, Newborn; D004054:Diethylstilbestrol / Q000494:pharmacology / Q000633:toxicity; D052244:Endocrine Disruptors / Q000494:pharmacology / Q000633:toxicity*; D005260:Female; D011495:Histone-Lysine N-Methyltransferase / Q000037:antagonists & inhibitors; D006657:Histones / Q000378:metabolism; D006801:Humans; D007248:Infertility, Male / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control; D008297:Male; D008745:Methylation / Q000187:drug effects; D051379:Mice; D018345:Mice, Knockout; D011499:Protein Processing, Post-Translational / Q000187:drug effects; D018160:Receptors, Cytoplasmic and Nuclear / Q000172:deficiency / Q000187:drug effects / Q000502:physiology*; D011960:Receptors, Estrogen / Q000819:agonists / Q000096:biosynthesis / Q000235:genetics; D018168:Receptors, Retinoic Acid / Q000187:drug effects / Q000502:physiology; D015398:Signal Transduction / Q000187:drug effects; D013091:Spermatogenesis / Q000187:drug effects / Q000502:physiology; D013737:Testis / Q000187:drug effects / Q000502:physiology; D014158:Transcription, Genetic / Q000187:drug effects
D052244:Endocrine Disruptors; D006657:Histones; D018160:Receptors, Cytoplasmic and Nuclear; D011960:Receptors, Estrogen; D018168:Receptors, Retinoic Acid; C099713:nuclear receptor subfamily 0, group B, member 2; D004054:Diethylstilbestrol; C533711:G9a protein, mouse; D011495:Histone-Lysine N-Methyltransferase